News Eli Lilly and Company Sao Paulo

Equities

LILY34

BRLILYBDR006

Market Closed - Sao Paulo Other stock markets 01:35:00 29/06/2024 am IST			5-day change	1st Jan Change
169 ^BRL	+1.86%		+3.00%	+80.92%

28/06	Atossa Therapeutics Doubles Z-Endoxifen Dose in Phase 2 Breast Cancer Study	MT
28/06	EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older	RE

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Atossa Therapeutics Doubles Z-Endoxifen Dose in Phase 2 Breast Cancer Study	28/06	MT
EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older	28/06	RE
India plans incentives for diabetes, obesity drug makers in 2026, government official says	28/06	RE
TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases	27/06	AQ
Augustine Therapeutics announces EUR17 million Series A1 financing round	27/06	AQ
Augustine Therapeutics N.V. announced that it expects to receive funding from a group of investors	26/06	CI
Top Midday Stories: Microsoft Hit with EU Antitrust Charges; Judge Blocks Swipe-Fee Settlement Between Visa, Mastercard and Retailers; Novo Nordisk Secures Chinese Approval for Weight-Loss Drug; Tesla, Ford Issue Recalls	25/06	MT
Eli Lilly Working With OpenAI to Develop Medicines Against Drug-Resistant Pathogens	25/06	DJ
Eli Lilly Teams Up With OpenAI to Develop Antimicrobials for Drug-Resistant Bacteria	25/06	MT
Eli Lilly: collaboration agreement with OpenAI	25/06	CF
Eli Lilly Partners With OpenAI for Developing Antimicrobials to Treat Drug-Resistant Bacteria	25/06	MT
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria	25/06	PR
Out with AI, in with defensive stocks	25/06
Novo Nordisk's Wegovy Weight-Loss Drug Gets Approval in China	25/06	DJ
ANALYST RECOMMENDATIONS : Capri Holdings, Adobe, Broadcom, Celanese, Admiral...	25/06
Truist Adjusts Price Target on Eli Lilly & Co. to $1,000 From $892 After Model Update, Maintains Buy Rating	25/06	MT
Trending : Lilly Anti-Obesity Drug Tirzepatide Reduces Sleep Apnea Severity in Studies	24/06	DJ
Wegovy-maker Novo Nordisk to spend $4.1 bln to boost US manufacturing	24/06	RE
Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update	24/06	DJ
Doctors must keep Ozempic prescriptions in check, Danish regulator says	24/06	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

David Ricks, CEO of Eli Lilly: A market of over a billion people

March 13, 2024 at 12:17 am IST